| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Renal Physiology, Vol 271, Issue 6 1166-F1172, Copyright © 1996 by American Physiological Society
ARTICLES |
K. Gurbanov, I. Rubinstein, A. Hoffman, Z. Abassi, O. S. Better and J. Winaver
Department of Physiology and Biophysics, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
The present study evaluated the effects and mechanisms of action of endothelin-1 (ET-1) on medullary and cortical blood flow (MBF and CBF, respectively). CBF and MBF were measured simultaneously by laser-Doppler flowmetry in anesthetized male Wistar rats. Bolus injection of ET-1 (1.0 nmol/kg iv) produced a sustained decrease in CBF (delta = -30%) and a transient increase in MBF (delta = +35%). The medullary vasodilation induced by ET-1 was observed with doses lower than that required to produce cortical vasoconstriction; was completely blocked by bosentan, a mixed ETA/B-receptor antagonist; and was mimicked by IRL-1620, a specific ETB-receptor agonist. In contrast, BQ-123, an ETA-receptor antagonist, failed to inhibit the ET-1-dependent medullary vasodilation but effectively blocked the cortical vasoconstriction induced by the peptide. Finally, inhibition of nitric oxide (NO) synthase completely abolished, whereas cylooxygenase inhibition attenuated, the effect of ET-1 on MBF. The data demonstrate that ET-1 exerts opposite effects on renal cortical and medullary circulation, i.e., ETA-receptor-mediated cortical vasoconstriction and ETB-mediated medullary vasodilation. Furthermore, the medullary vasodilation induced by ET-1 is dependent on the NO system and, to a lesser extent, on prostaglandin generation.
This article has been cited by other articles:
|
|
 |
|
  M. P. Schneider, Y. Ge, D. M. Pollock, J. S. Pollock, and D. E. Kohan Collecting Duct-Derived Endothelin Regulates Arterial Pressure and Na Excretion via Nitric Oxide Hypertension, June 1, 2008; 51(6): 1605 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nakano, J. S. Pollock, and D. M. Pollock Renal medullary ETB receptors produce diuresis and natriuresis via NOS1 Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1205 - F1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Abassi, B. Bishara, T. Karram, S. Khatib, J. Winaver, and A. Hoffman Adverse effects of pneumoperitoneum on renal function: involvement of the endothelin and nitric oxide systems Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R842 - R850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Winaver, E. Ovcharenko, I. Rubinstein, K. Gurbanov, P. Pollesello, B. Bishara, A. Hoffman, and Z. Abassi Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2007 - H2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, A. F. Chen, and D. H. Wang ETA receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2005 - H2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Williams, X. Zhao, M. H. Wang, J. D. Imig, and D. M. Pollock Peroxisome Proliferator-Activated Receptor-{alpha} Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor Blockade Hypertension, August 1, 2005; 46(2): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maeda, T. Miyauchi, M. Iemitsu, T. Tanabe, K. Goto, I. Yamaguchi, and M. Matsuda Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E609 - E614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vassileva, C. Mountain, and D. M. Pollock Functional Role of ETB Receptors in the Renal Medulla Hypertension, June 1, 2003; 41(6): 1359 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Mattson Importance of the renal medullary circulation in the control of sodium excretion and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R13 - R27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Sasser, J. S. Pollock, and D. M. Pollock Renal endothelin in chronic angiotensin II hypertension Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R243 - R248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hantz, A. Adesuyi, and O. Adebayo Differential Effects of U46619 on Renal Regional Hemodynamics in the Rat: Involvement of Endothelin J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 372 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Pollock and J. S. Pollock Evidence for endothelin involvement in the response to high salt Am J Physiol Renal Physiol, July 1, 2001; 281(1): F144 - F150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. POLLOCK Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1 Physiol Genomics, June 6, 2001; 6(1): 39 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Abassi, S. Brodsky, O. Gealekman, I. Rubinstein, A. Hoffman, and J. Winaver Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure Am J Physiol Renal Physiol, January 1, 2001; 280(1): F43 - F53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Hercule and A. O. Oyekan Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2132 - R2141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Reinhart, L. C. Preusser, T. J. Opgenorth, C. D. Wegner, and B. F. Cox Endothelin and ETA receptors in long-term arterial pressure homeostasis in conscious nonhuman primates Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1701 - R1706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mizutani, K. Okajima, M. Uchiba, and T. Noguchi Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation Blood, June 15, 2000; 95(12): 3781 - 3787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Hercule and A. O. Oyekan Cytochrome P450 omega /omega -1 Hydroxylase-Derived Eicosanoids Contribute to EndothelinA and EndothelinB Receptor-Mediated Vasoconstriction to Endothelin-1 in the Rat Preglomerular Arteriole J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1153 - 1160. [Abstract] [Full Text]
|
|
|
|
|
|
A. Hoffman, Z. A. Abassi, S. Brodsky, R. Ramadan, and J. Winaver Mechanisms of Big Endothelin-1-Induced Diuresis and Natriuresis : Role of ETB Receptors Hypertension, March 1, 2000; 35(3): 732 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Pollock, G. H. Allcock, A. Krishnan, B. D. Dayton, and J. S. Pollock Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats Am J Physiol Renal Physiol, February 1, 2000; 278(2): F279 - F286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brodsky, K. Gurbanov, Z. Abassi, A. Hoffman, R. R. Ruffolo Jr, G. Z. Feuerstein, and J. Winaver Effects of Eprosartan on Renal Function and Cardiac Hypertrophy in Rats With Experimental Heart Failure Hypertension, October 1, 1998; 32(4): 746 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Abassi, K. Gurbanov, I. Rubinstein, O. S. Better, A. Hoffman, and J. Winaver Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide Am J Physiol Renal Physiol, April 1, 1998; 274(4): F766 - F774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Bestle, N. V. Olsen, T. D. Poulsen, R. Roach, N. Fogh-Andersen, and P. Bie Prolonged hypobaric hypoxemia attenuates vasopressin secretion and renal response to osmostimulation in men J Appl Physiol, May 1, 2002; 92(5): 1911 - 1922. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
